ClinicalTrials.Veeva

Menu

Enzyme Activity of Matrix Metalloproteinases in the Serum of Patients With Malignant Obstructive Hyperbilirubinemia Before and After PTBD

I

Institut za Rehabilitaciju Sokobanjska Beograd

Status

Unknown

Conditions

Matrix Metalloproteinase

Treatments

Procedure: Percutaneous biliary drainage

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to detect differences in the enzymatic activity of matrix metalloproteinases in patients with malignant obstructive hyperbilirubinemia before and after percutaneous biliary drainage.

Full description

This study will be designed as a prospective cohort study involving the collection of peripheral blood samples before and one month after percutaneous biliary drainage for further molecular biochemical analysis (measurement of serum matrix metalloproteinase activity). Biochemical analyzes are preceded by the entry of data relevant to the research (demographic, anamnestic, clinical and biochemical).

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

pathological confirmation or imaging data confirming malignant disease causing bile duct obstruction, performance status 0-1

Exclusion criteria

terminally ill patients, performance status >2, hepatic decompensation, severe underlying cardiac or renal diseases and coagulation disorders.

Trial design

30 participants in 1 patient group

Matrix Metalloproteinases
Description:
Value of serum matrix metalloproteinase activity before and one month after PTBD
Treatment:
Procedure: Percutaneous biliary drainage

Trial contacts and locations

1

Loading...

Central trial contact

Aleksandar N Filipovic, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems